These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21047033)

  • 1. Human papillomavirus disease and vaccines in adolescents.
    Moscicki AB
    Adolesc Med State Art Rev; 2010 Aug; 21(2):347-63, x-xi. PubMed ID: 21047033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccines: who should get them and why?
    Paulus S; Dobson S
    Adv Exp Med Biol; 2008; 609():145-53. PubMed ID: 18193663
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical approval: Trials of an anticancer jab.
    Clayton J
    Nature; 2012 Aug; 488(7413):S4-6. PubMed ID: 22932438
    [No Abstract]   [Full Text] [Related]  

  • 7. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 8. Human papillomavirus and cervical cancer.
    Crosbie EJ; Einstein MH; Franceschi S; Kitchener HC
    Lancet; 2013 Sep; 382(9895):889-99. PubMed ID: 23618600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
    Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India.
    Kaur P; Mehrotra R; Rengaswamy S; Kaur T; Hariprasad R; Mehendale SM; Rajaraman P; Rath GK; Bhatla N; Krishnan S; Nayyar A; Swaminathan S
    Indian J Med Res; 2017 Aug; 146(2):153-157. PubMed ID: 29265015
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical cancer in the human papillomavirus vaccination era.
    Tay SK
    Curr Opin Obstet Gynecol; 2012 Feb; 24(1):3-7. PubMed ID: 22123221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccination: Ongoing challenges and future directions.
    Dilley S; Miller KM; Huh WK
    Gynecol Oncol; 2020 Feb; 156(2):498-502. PubMed ID: 31848025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L; Senatore S; Franco E
    Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 19. Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study.
    Matthijsse SM; Hontelez JA; Naber SK; Rozemeijer K; de Kok IM; Bakker R; van Ballegooijen M; van Rosmalen J; de Vlas SJ
    J Infect Dis; 2016 Sep; 214(6):854-61. PubMed ID: 27330051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new challenges in the prevention of cervical cancer.
    Monsonego J
    Vaccine; 2008 Mar; 26 Suppl 1():A4-6. PubMed ID: 18642457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.